Ibrutinib as an antitumor immunomodulator in patients with refractory chronic lymphocytic leukemia

Ibrutinib has emerged as a promising therapy for patients with chronic lymphocytic leukemia (CLL) who are nonresponsive to standard therapies. The refractory state of monocytes and T-cell exhaustion in patients with CLL could explain the morbidity and mortality reported in these patients. We studied...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:Oncoimmunology
Main Authors: Cubillos-Zapata, Carolina, Avendaño-Ortiz, Jose, Córdoba, Raúl, Hernández-Jiménez, Enrique, Toledano, Victor, Pérez de Diego, Rebeca, López-Collazo, Eduardo
Formáid: Artigo
Teanga:Inglês
Foilsithe: Taylor & Francis 2016
Ábhair:
Brief Report
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5213769/
https://ncbi.nlm.nih.gov/pubmed/28123879
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1242544
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla